Price
CHART BY
Frequently asked questions
What is Intellego's market capitalization?
The market capitalization of Intellego is $158.86M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Intellego?
Intellego's Earnings Per Share (EPS) over the trailing twelve months (TTM) is 0.681. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Intellego's stock?
Currently, 1 analysts cover Intellego's stock, with a consensus target price of $30.69. Analyst ratings provide insights into the stock's expected performance.
What is Intellego's revenue over the trailing twelve months?
Over the trailing twelve months, Intellego reported a revenue of $75.50M.
What is the EBITDA for Intellego?
Intellego's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $40.20M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Intellego?
Intellego has a free cash flow of $5.66M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Intellego have, and what sector and industry does it belong to?
Intellego employs approximately 63 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
Financials
- Market Cap
- $158.86M
- EPS (TTM)
- 0.681
- Revenue (TTM)
- $75.50M
- EBITDA (TTM)
- $40.20M
- Free Cashflow (TTM)
- $5.66M
Analyst Ratings
The price target is $30.69 and the stock is covered by 1 analysts.
Buy
1
Hold
0
Sell
0
Information
Intellego Technologies AB engages in the research, development, and trade of photochromic indicator technology. It offers an ink that changes in color based on exposure to ultraviolet (UV) irradiation. The firm carries the SmartSun Band that indicates UV vulnerability and mitigates sunburn and long-term skin damage. The company was founded by Claes Ian Lindahl on August 31, 2011 and is headquartered in Stockholm, Sweden.
- Employees
- 63
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- SE0016075063
- Primary Ticker
- INT
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet